-
1
المؤلفون: Palvi Gupta, Jonathan Talbot, Per-Olof Thuresson, Nancy Vander Velde
المصدر: Advances in Therapy
مصطلحات موضوعية: Oncology, 030213 general clinical medicine, medicine.medical_specialty, Immunoconjugates, Diffuse large B cell lymphoma, 03 medical and health sciences, 0302 clinical medicine, Refractory, Indirect Treatment, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Refractory Diffuse Large B-Cell Lymphoma, Pharmacology (medical), Clinical efficacy, Original Research, business.industry, Systematic literature review, Hematopoietic Stem Cell Transplantation, Polatuzumab vedotin, Antibodies, Monoclonal, General Medicine, medicine.disease, Transplantation, Treatment Outcome, Systematic review, 030220 oncology & carcinogenesis, Lymphoma, Large B-Cell, Diffuse, Rituximab, business, Diffuse large B-cell lymphoma
-
2
المؤلفون: Sarah Hofmann, Aino Launonen, Sebastian Himmler, Per-Olof Thuresson, Ulrich Dünzinger, Dennis A Ostwald
المصدر: Journal of Comparative Effectiveness Research. 9:1017-1026
مصطلحات موضوعية: Adult, Male, Follicular lymphoma, Antibodies, Monoclonal, Humanized, chemistry.chemical_compound, Antineoplastic Agents, Immunological, Obinutuzumab, Chemoimmunotherapy, Germany, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Lymphoma, Follicular, Productivity, business.industry, Health Policy, Societal impact of nanotechnology, Middle Aged, medicine.disease, First line treatment, Treatment Outcome, chemistry, Unpaid work, Economic evaluation, Female, Rituximab, business, Demography
-
3
المؤلفون: Per-Olof Thuresson, Ella X Du, Anthony Masaquel, Federico Felizzi, Jia Li, Keith A. Betts, Ibou Dieye, Mathias Schulz
المصدر: Journal of comparative effectiveness research. 9(14)
مصطلحات موضوعية: Bendamustine, Oncology, Adult, medicine.medical_specialty, Immunoconjugates, Adolescent, Cost effectiveness, Cost-Benefit Analysis, Antineoplastic Agents, 03 medical and health sciences, 0302 clinical medicine, Refractory, Internal medicine, medicine, Bendamustine Hydrochloride, Humans, Survival analysis, Aged, business.industry, Health Policy, Antibodies, Monoclonal, Middle Aged, medicine.disease, Lymphoma, Polatuzumab vedotin, Survival Rate, Treatment Outcome, 030220 oncology & carcinogenesis, Rituximab, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma, 030215 immunology, medicine.drug
-
4
المؤلفون: R. Ho, Andrea Knapp, Per-Olof Thuresson, Irene Canales Ruiz, Leonardo Simonella, Aino Launonen
المصدر: Blood. 138:3577-3577
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Context (language use), Cell Biology, Hematology, medicine.disease, Biochemistry, Clinical trial, International Prognostic Index, Patient-Relevant Outcomes, Internal medicine, Medicine, business, Diffuse large B-cell lymphoma
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bf181e90dd44995056a6038e79617396
https://doi.org/10.1182/blood-2021-146822 -
5
المصدر: Blood. 136:41-42
مصطلحات موضوعية: Oncology, Bendamustine, medicine.medical_specialty, business.industry, Immunology, Hazard ratio, Cell Biology, Hematology, GemOx, medicine.disease, Biochemistry, Polatuzumab vedotin, Cancer registry, Interquartile range, Internal medicine, medicine, Rituximab, business, Diffuse large B-cell lymphoma, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::da7f1394576c77e707a0b18eb61613ce
https://doi.org/10.1182/blood-2020-137529 -
6
المؤلفون: Noman Paracha, Federico Felizzi, Per-Olof Thuresson
المصدر: Value in Health. 22:S770-S771
مصطلحات موضوعية: Finance, Investment decisions, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Market access, business
-
7
المؤلفون: Gregory F. Guzauskas, Per-Olof Thuresson, Keith L Dawson, David L. Veenstra, Anthony Masaquel
المصدر: Leukemialymphoma. 60(7)
مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Cost effectiveness, medicine.medical_treatment, Follicular lymphoma, Antibodies, Monoclonal, Humanized, Drug Costs, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Obinutuzumab, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Bendamustine Hydrochloride, Humans, Cyclophosphamide, Lymphoma, Follicular, Aged, Aged, 80 and over, Chemotherapy, business.industry, Hematology, Middle Aged, medicine.disease, Prognosis, United States, Survival Rate, chemistry, Doxorubicin, Vincristine, 030220 oncology & carcinogenesis, Prednisone, Rituximab, Female, Quality-Adjusted Life Years, business, 030215 immunology, medicine.drug, Follow-Up Studies
-
8
المؤلفون: Per-Olof Thuresson, Federico Felizzi, Aino Launonen
المصدر: Value in Health. 23:S289
مصطلحات موضوعية: Matching (statistics), Mathematical optimization, Cost effectiveness, Computer science, Health Policy, Public Health, Environmental and Occupational Health
-
9
المصدر: Blood. 134:4767-4767
مصطلحات موضوعية: Oncology, Bendamustine, medicine.medical_specialty, business.industry, Immunology, Follicular lymphoma, Cell Biology, Hematology, medicine.disease, Biochemistry, Polatuzumab vedotin, Lymphoma, Quality of life, Internal medicine, Relapsed refractory, medicine, Rituximab, business, Diffuse large B-cell lymphoma, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6d1adb6fab02efde76ae68abab7fa4bd
https://doi.org/10.1182/blood-2019-123688 -
10
المؤلفون: Federico Felizzi, P. Orfanos, Per-Olof Thuresson
المصدر: Value in Health. 22:S862
مصطلحات موضوعية: Oncology, medicine.medical_specialty, chemistry.chemical_compound, Tocilizumab, chemistry, business.industry, EQ-5D, Health Policy, Internal medicine, Public Health, Environmental and Occupational Health, medicine, business